Krishna Institute of Medical Sciences Limited has made a regulatory disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding an upcoming Analyst/Institutional Investor Meeting.
The meeting is scheduled for November 19, 2026, and will be held at the Investec Pune Confluence in Pune, India. The event is classified as a Group Meeting.
The company explicitly states that no Unpublished Price Sensitive Information will be shared during the meeting. The disclosure notes that the schedule is subject to change due to any exigencies.
The communication was digitally signed by Nagajayanthi Juttur Raghavendra Das, who serves as Company Secretary & Compliance Officer for Krishna Institute of Medical Sciences Limited, on November 10, 2026, at 13:41:35 IST.
The disclosure was submitted to both Bombay Stock Exchange Ltd (BSE) and National Stock Exchange (NSE) for information and records.